The AIRTIVITY® Study: A Study to Find Out Whether BI 1291583 Helps People With Bronchiectasis
This study is open to adults with bronchiectasis. People can participate in this study if they produce sputum and have had flare-ups (also called exacerbations). The purpose of this study is to find ...
A Phase II Study of Ensifentrine in Non-Cystic Fibrosis Bronchiectasis
This study is a randomized, double-blind, placebo-controlled study designed to assess the efficacy and safety of ensifentrine inhalation suspension (3 mg) delivered twice daily via standard jet nebuli...
Top Cities for Bronchiectasis Clinical Trials
Bronchiectasis clinical trials are recruiting across 17 cities. Here are the cities with the most active studies:
About Bronchiectasis
Bronchiectasis is a chronic condition where the bronchial tubes of the lungs are permanently widened, leading to a buildup of mucus and repeated infections. It can result from various causes including infections and genetic conditions. Treatment includes airway clearance, antibiotics, and anti-inflammatory medications.
Clinical trials are advancing new treatments for bronchiectasis. Currently, 2 studies are recruiting a combined 1,860 participants across the United States. Research is being conducted by 2 organizations including Boehringer Ingelheim, Verona Pharma plc.
2026 Bronchiectasis Research Landscape
As of March 2026, the bronchiectasis clinical trial landscape includes 2 actively recruiting studies across 17 cities in the United States. These studies are collectively seeking 1,860 participants, with an average enrollment target of 930 per study.
Research is being led by 2 different organizations, including Boehringer Ingelheim, Verona Pharma plc.
Geographically, bronchiectasis trials are most concentrated in Birmingham, Alabama (2 trials); Sacramento, California (2 trials); Denver, Colorado (2 trials); Anchorage, Alaska (1 trial); Phoenix, Arizona (1 trial) and 7 other cities.
Featured Bronchiectasis Studies
Highlighted recruiting studies for bronchiectasis, selected by enrollment size and research scope.
The AIRTIVITY® Study: A Study to Find Out Whether BI 1291583 Helps People With Bronchiectasis
This study is open to adults with bronchiectasis. People can participate in this study if they produce sputum and have had flare-ups (also called exacerbations). The purpose of this study is to find out whether a medicine called BI 1291583 helps people with bronchiectasis. Participants are put into 2 groups randomly, which means by chance. One group takes BI 1291583 tablets and the other group ta...
A Phase II Study of Ensifentrine in Non-Cystic Fibrosis Bronchiectasis
This study is a randomized, double-blind, placebo-controlled study designed to assess the efficacy and safety of ensifentrine inhalation suspension (3 mg) delivered twice daily via standard jet nebulizer over at least 24 weeks, compared to placebo, in subjects with non-cystic fibrosis bronchiectasis (NCFBE).
Frequently Asked Questions About Bronchiectasis Clinical Trials
Are there bronchiectasis clinical trials near me?
Yes, there are 2 bronchiectasis clinical trials currently recruiting across 17+ cities in the United States, including Birmingham, Alabama; Sacramento, California; Denver, Colorado. Browse the studies above to find one at a location convenient for you.
How do I join a bronchiectasis clinical trial?
To join a bronchiectasis clinical trial: 1) Browse the available studies on this page, 2) Click on a study that interests you, 3) Check the study locations to find a site near you, 4) Review the eligibility criteria, and 5) Contact the study site or complete the eligibility form. The process is free and you can withdraw at any time.
Are bronchiectasis clinical trials free?
Yes, participation in bronchiectasis clinical trials is free. Study-related treatments, medical tests, and doctor visits are provided at no cost to participants. Many studies also offer compensation for your time and travel expenses.
What types of bronchiectasis treatments are being studied?
Current bronchiectasis clinical trials are testing a range of approaches. These include new drugs, combination therapies, medical devices, and other interventions sponsored by 2 research organizations.
Is it safe to participate in bronchiectasis clinical trials?
Clinical trials are carefully regulated by the FDA and institutional review boards (IRBs). All trials must follow strict safety protocols, and participants receive close medical monitoring throughout the study. You can withdraw from a trial at any time without penalty.
Data updated March 1, 2026 from ClinicalTrials.gov
About This Data
Clinical trial information on this page is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health (NIH) and National Library of Medicine (NLM). Study data is refreshed every hour to ensure accuracy.
Medical Disclaimer: The information provided on this page is for informational purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider before making decisions about clinical trial participation or changes to your treatment plan.
Page reviewed by the HelloStudys Research Team · Last updated March 1, 2026 · Data from ClinicalTrials.gov